Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Dayto himbin
(2013) Mol Cancer Ther
Epub 2003 Sep 11
Potent PAR2 biased agonist
Meropenem ethoxy-PEPy Dayto himbinMeropenem is an ultra broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. Meropenem was originally developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca with the brand names Merrem and Meronem. Other brand names include Zwipen (India, Marketed by Nucleus) Mepem
US$ 26.95
US$ 44.95
US$ 54.99
US$ 29.99
US$ 156.95
US$ 193.50
US$ 179.50
US$ 120.00
US$ 24.99
US$ 29.99
US$ 13.95
US$ 31.95
US$ 23.00
US$ 180.00
US$ 29.99